Past Events

The international meeting of scientists to share recent developments, exchange ideas, explore new directions and initiate a possible collaboration in the atomic spectrometry area and in other spectroscopy techniques. Leading scientists and researchers will be invited to present their most up-to-date results on this conference, to exchange exciting ideas and experiences as well as look into future development.

ARROWHEAD’S ANNUAL PAIN THERAPEUTICS SUMMIT is the US’s premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors. This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.

The 7th annual Pharma-Bio-Med & BioSciences Information and CI Conference & Exposition is the premier event in Europe that is tailored to the interests of information, library, knowledge management and informatics practitioners working with competitor intelligence and bioscience data information in industries such as pharma and biotech, food, nutrition, agriculture/crop science cosmetics, diagnostics and devices, academic and government health sciences fields.

The efficient conversion of a chemical process into a process for manufacture on tonnage scale has always been of importance in the chemical and pharmaceutical industries. However, in the current economic and regulatory climate, it has become increasingly vital and challenging to do so efficiently. At our Organic Process Research & Development Conference, you will hear detailed presentations and case studies from top international chemists. Our hand-picked programme of speakers has been put together specifically for an industrial audience. They will discuss the latest issues relating to synthetic route design, development and optimisation in the pharmaceutical, fine chemical and allied fields. Unlike other conferences, practically all our speakers are experts from industry, which means the ideas and information you take home will be directly applicable to your own work.

Personalized medicine has the potential to revolutionize medical care by utilizing an improved understanding of genetics and molecular biology to allow for better diagnostic tests, more precise diagnoses, greater predictability of disease course, and improved patient safety by selecting not only the right drug for a patient but also the proper dosage to reduce adverse effects. Speakers and panelists will answer the following key questions: *What types of challenges need to be met in order to realize the true commercial potential of personalized medicine? *Will insurers fund the genomic revolution? *What types of validation requirements are they looking for? *What will be their criteria for reimbursement? *What are the real-world challenges to successful adoption of molecular/companion diagnostics? *Who needs to partner in order to advance the field of personalized medicine? *What are the goals, utility and challenges associated with Rx-Dx partnerships? *How and when are relationships being initiated today? *How are companies navigating their way through the world's regulatory bodies? *What kind of impact are Pharmacy Benefit Managers (PBMs) and for that matter new genetic testing benefit managers going to have on the future of personalized medicine? *What types of efforts are being made to influence adoption via physician education?

Conference topics Chemical modification, degradation, biodegradation, ageing, stabilization, fire retardancy, recycling and reuse of bulk polymers, polymer blends, filled systems and polymer coatings.

Whether you are developing a brand new process or optimizing an existing synthetic route, the aims are always the same: • Achieving greater process efficiency, yield and throughput. • Eliminating unsafe and non-green processes and materials. • Decreasing the costs and number of steps involved. Since the first conference in 1994, The Scale-Up of Chemical Processes has become the major international forum for the discussion of all these aspects of scale-up and more in the pharmaceutical, fine chemical and allied fields. Key speakers will present case studies and examples of some of the pitfalls and problems they encountered and how they overcame them. With unparalleled networking opportunities, this broad-based conference is the best place to learn about and discuss the latest novel ideas and techniques with the key people in the industry.

The 76th Prague Meetings on Macromolecules: Polymers in Medicine will focus on the latest innovative development in drug delivery systems. Meeting brings together multi-disciplinary researchers from both academia and industry in the areas of pharmaceutics, polymer and materials science, imaging, cell and molecular biology, genetic, and medicine.

Given the crisis facing the pharmaceutical industry in the translation of early stage drug discovery results, a different set of tools, concerned with algorithms and methods for developing best in class drugs that engage biological targets with kinetically optimized potency and selectivity will need to be refined. In this conference, we bring to focus recent advancements in this field from an experienced faculty. Keynote Address: Binding Kinetics in Drug Discovery David Swinney, Ph.D., CEO, Institute for Rare and Neglected Diseases Drug Discovery (iRND3)

Bio-IT World Asia 2012 will bring together, life sciences, pharmaceutical, informatics and IT professionals from all over Asia and the rest of the world to one unique location. The Event provides the perfect venue to share information and discuss enabling technologies that are driving biomedical research and the drug development process. This year’s event will include dedicated tracks that include: IT Infrastructure and the Cloud Drug Discovery Informatics Bioinformatics NGS Data Management and Interpretation

The iMedicine & Mobile Life Sciences World Summit provides a unique opportunity for mHealth developers to showcase and present their new technologies to a global eHealth audience; and for healthcare practitioners and pharmaceutical executives to present case studies on clinical or medical educational needs or outcomes of App implementation to highlight progress, challenges, and opportunities in the highly dynamic digital age.

The 2012 Spring Meeting of the European Materials Research Society (E-MRS) and exhibit will be held at the Palais des Congrès in Strasbourg from May 14th-18th. This meeting will mark the 30th Spring conference since the foundation of E-MRS, in 1983, and will consist of 25 parallel symposia. The major themes of the conference will be “Materials for Energy”, “Bio / Organic / Polymeric Materials”, “Materials for Electronic / Photonic / Plasmonic Applications, “Advanced Materials and Nano Materials” and “Methods and Analysis”. The scientific programme will highlight the latest advances in international materials research and key novel applications. The conference will be enriched by an industrial exhibition and a series of satellite events to enhance our scientific curiosity for the wonderful and exciting world of functional materials and their applications. The main satellite events are the Nature Materials / E-MRS one day workshop devoted to “Frontiers in Materials: Spintronics”, the ACS Nano Lectureship Award, and the Young Scientist Tutorial on “Characterization Techniques for Thin-Film Solar Cells”. Moreover, a special workshop devoted to oxide electronics will be also organized by Wiley. In summary, the E-MRS 2012 Spring Meeting will include many international high level scientific events in one place. I predict this to be one the largest and most exciting E-MRS Conference ever held in Strasbourg. Don’t miss it, we count on you and look forward to your active contributions and participation.

This 3-day conference and exhibition has been designed to fill a gap in the conference field, providing a forum where industry and academia can meet to discuss new synthetic methodology and chiral chemistry, and how practical this methodology is from an industrial viewpoint. Industry rarely devises new synthetic methods to perform each step in the synthetic route but relies on using and modifying methods which have been discovered within academia. It is therefore essential that the industrial chemist, whether in early research and discovery or process chemistry, is aware of the latest developments in synthetic organic chemistry, so that efficient and practical methods for synthesising new molecules are devised. Emphasis will be on the state of the art and will provide directions for future work. Industrial chemical case studies where key reactions have been used, either in discovery or in development, will be provided.

The 8th Annual PEGS encompasses 12 tracks, 15 short courses, and a pre-conference partnering forum for showcasing early stage companies. Topics span from early stage discovery of new methods for protein expression and antibody engineering, to improved analytical techniques, and clinical results in the most promising areas of biotechnology. There is tremendous momentum and investment in biologics, and the PEGS conference offers an unparalleled view of the field. Conference streams include: - Strategies for Successful Protein Drug Discovery and Development - Conquering Expression Challenges to Optimize Protein Production - Overcoming Challenges in Characterization, Aggregation and Immunogenicity - Ground Breaking Design and Development of Safe and Efficacious Antibody Products

CHI’s Drug Discovery Chemistry event is known as THE event focusing on novel small molecules as therapeutic targets with a strong emphasis on the chemistry based approach. This unique event brings together top experts with diverse chemical, biochemical and life science backgrounds to discuss and brainstorm on cutting edge research, discovery and successes in hot and up and coming areas such as Fragment-based Drug Discovery, Physicochemical Drug Properties, HCV, Antibacterial Drug Development, Protein-Protein Interaction and Anti-Inflammatories.

These series of conferences aim to bring together scientists from the supercontinent of Eurasia (European and Asiatic countries) and encourage friendship and scientific collaboration. Chairman of Eurasia 12 is the Emeritus Professor of the University of Ioannina, Greece, Nick Hadjiliadis.

The efficient conversion of a chemical process into a process for manufacture on tonnage scale has always been of importance in the chemical and pharmaceutical industries. However, in the current economic and regulatory climate, it has become increasingly vital and challenging to do so efficiently. At Organic Process Research & Development Conference, you will hear detailed presentations and case studies from top international chemists. Our hand-picked programme of speakers has been put together specifically for an industrial audience. They will discuss the latest issues relating to synthetic route design, development and optimisation in the pharmaceutical, fine chemical and allied fields.

This conference will bring together leading researchers investigating computational chemistry and biology techniques as applied to advancing our ability to predict, diagnose and modulate human disease. This broad and multidisciplinary meeting will explore the major challenges in drug discovery and development where innovation in computational approaches and tools can really make a significant and tangible contribution towards novel treatments. You should attend this conference if you are a researcher interested in drug discovery, or developing or using computational approaches to the development of therapeutics, or if you are a key decision maker in a pharmaceutical or biotechnology company. The organisers warmly encourage submission of abstracts, which will be considered both for oral and for poster presentation. Each of the sessions, which progress from identifying disease mechanisms to implementing new therapeutic and diagnostic approaches in the clinic, will bring together experts in both the biomedical and the computational aspects of the topic under discussion. Sessions chairs will encourage discussion and contribution from the attendees. Session topics • Clinical implications of individual genomes • Metabolism and biomarkers • Computational systems biology • Discovery of chemical probes • Modelling xenobiotic metabolism

Traumatic Brain Injury (TBI) is a major cause of death and disability globally and is considered a serious public health problem. In the US, an estimated 1.7 million people sustain a TBI every year, and over 30 percent of all reported injury-related deaths list TBI as a contributing factor. Moreover, mild traumatic brain injury is the most common combat-related injury and along with spinal cord injury, TBI accounts for nearly 25 percent of combat casualties. Treatment of TBI and especially acute TBI is still a major unmet medical need. Therapies that prove an ability to limit the damage done to the brain and improve clinical outcomes of patients of TBI will have a major impact on the global pharmaceutical market. Although past clinical trials for new therapies have ended in failure, there is indeed renewed interest in this field and with recent initiatives from both the US Congress and Department of Defense to improve treatment options for TBI patients, the time has come for a rethinking of the potential for pharmaceutical management of this condition.